Latest News from: University of Kansas Cancer Center

Filters close
Released: 12-Nov-2024 3:50 PM EST
Traumatic Childhood Events May Increase Risk for Long-Term Health Effects in Breast Cancer Survivors
University of Kansas Cancer Center

Childhood trauma can increase a breast cancer survivor’s chance of experiencing more severe and longer-lasting treatment-related anxiety, depression and fatigue, as well as reduced cognitive function, years after cancer treatment has ended, according to a preliminary study led by Jamie Myers, Ph.D., FAAN, research associate professor at the University of Kansas School of Nursing.

Newswise: KU Cancer Center Leads National Trial Testing Vaccine for Colon Cancer in People with Lynch Syndrome
Released: 23-Oct-2024 2:35 PM EDT
KU Cancer Center Leads National Trial Testing Vaccine for Colon Cancer in People with Lynch Syndrome
University of Kansas Cancer Center

A researcher at The University of Kansas Cancer Center is leading a national clinical trial to test a combination vaccine to prevent colon cancer in people with Lynch syndrome.

Released: 18-Oct-2024 12:25 PM EDT
Study Finds Opt-Out Treatment Helps Smokers Quit, Even Those with Low Motivation
University of Kansas Cancer Center

Study Finds Opt-Out Treatment Helps Smokers Quit, Even Those with Low Motivation

Newswise: A Precision-Medicine Initiative Sponsored by the National Cancer Institute Aims to Improve Treatment for the Most Common Form of Leukemia in Adults
Released: 23-Sep-2024 2:05 PM EDT
A Precision-Medicine Initiative Sponsored by the National Cancer Institute Aims to Improve Treatment for the Most Common Form of Leukemia in Adults
University of Kansas Cancer Center

The University of Kansas Cancer Center is part of the myeloMATCH trial, a large, coordinated effort to improve patient outcomes through targeted treatments for people with acute myeloid leukemia or myelodysplastic syndrome.

Newswise: New Study Aims to Improve Bladder Cancer Treatment with High-Dose Intravenous Vitamin C
Released: 12-Aug-2024 11:05 AM EDT
New Study Aims to Improve Bladder Cancer Treatment with High-Dose Intravenous Vitamin C
University of Kansas Cancer Center

Researchers at The University of Kansas Cancer Center have secured a $3.6 million grant from the U.S. Department of Defense to study high-dose intravenous Vitamin C for treating muscle-invasive bladder cancer. This type of cancer occurs when cancer cells spread to the muscle layer of the bladder wall.

Newswise: Anthony Sung, MD, named director of Center for Survivorship and Patient-Oriented Research
Released: 23-Jul-2024 9:05 AM EDT
Anthony Sung, MD, named director of Center for Survivorship and Patient-Oriented Research
University of Kansas Cancer Center

Anthony Sung, MD, has been named the A. Drue Jennings Professor in Medical Oncology and the director of the Center for Survivorship and Patient-Oriented Research at The University of Kansas Cancer Center.

Released: 14-May-2024 1:05 PM EDT
NIH renews COBRE grant for Kansas Institute for Precision Medicine
University of Kansas Cancer Center

The Kansas Institute for Precision Medicine (KIPM) will continue its mission to improve health care by training physicians and scientists in precision medicine and supporting their research, thanks to a renewed Centers of Biomedical Research Excellence (COBRE) award from the National Institute of General Medical Sciences, part of the National Institutes of Health.

Newswise: KU Cancer Center Researcher Secures $1.4M Grant to Develop Peptide Therapy for Prostate Cancer
Released: 29-Mar-2024 11:05 AM EDT
KU Cancer Center Researcher Secures $1.4M Grant to Develop Peptide Therapy for Prostate Cancer
University of Kansas Cancer Center

Benyi Li, MD, PhD, professor in the Department of Urology and member of The University of Kansas Cancer Center, has received a nearly $1.4 million grant from the U.S. Department of Defense to develop a short peptide-based therapy for prostate cancer patients.

Newswise: Pool Cool Makes Fun in the Sun Safe
Released: 4-Mar-2024 3:05 PM EST
Pool Cool Makes Fun in the Sun Safe
University of Kansas Cancer Center

Pool Cool is a program designed to educate young people in The University of Kansas Cancer Center’s catchment area on sun safety behaviors.

Newswise: Researchers Look at Ways to Target Early Breast Cancer Progression
Released: 22-Feb-2024 3:05 PM EST
Researchers Look at Ways to Target Early Breast Cancer Progression
University of Kansas Cancer Center

A researcher at The University of Kansas Cancer Center has received a $930,000 grant from the U.S. Department of Defense to study a new targeted therapy option for people diagnosed with ductal carcinoma in situ (DCIS).

Newswise: KU Cancer Center receives $2.4 million grant to foster the next generation of translational scientists
Released: 24-Oct-2023 3:05 PM EDT
KU Cancer Center receives $2.4 million grant to foster the next generation of translational scientists
University of Kansas Cancer Center

In order to grow and train future clinical and translational scientists, The University of Kansas Cancer Center has received a $2.4 million grant from the National Cancer Institute (NCI).

Newswise: KU Cancer Center receives historic $100 million gift from Sunderland Foundation to support new cancer research and care facility
Released: 27-Jun-2023 9:05 PM EDT
KU Cancer Center receives historic $100 million gift from Sunderland Foundation to support new cancer research and care facility
University of Kansas Cancer Center

The University of Kansas Cancer Center has received a $100 million lead gift to build a new, state-of-the-art destination cancer center. This gift is both the largest gift ever given by the Sunderland Foundation and the largest ever received by the University of Kansas and The University of Kansas Health System.

Released: 31-May-2023 2:55 PM EDT
Optimizing the Immune System to Beat Cancer
University of Kansas Cancer Center

Chimeric antigen receptor (CAR) T-cell therapy amplifies the immune system’s ability to recognize and kill cancer cells. The first CAR T-cell therapy was approved by the Food and Drug Administration (FDA) in 2017. Today, there are 6 FDA-approved CAR-based therapies to treat certain types of leukemia, lymphoma and myeloma, all of which are available at The University of Kansas Cancer Center.

Newswise: KU Cancer Center uses art to reach underserved communities
Released: 23-Feb-2023 4:35 PM EST
KU Cancer Center uses art to reach underserved communities
University of Kansas Cancer Center

The mural, designed in collaboration with members of organizations in the surrounding urban community, is one part of the The University of Kansas Cancer Center’s broader campaign to increase the participation of minority and underserved populations in clinical trials.

Newswise: KU Medical Center researchers receive R01 grant from National Cancer Institute to increase targeted cancer treatments to rural cancer patients
Released: 16-Nov-2022 2:40 PM EST
KU Medical Center researchers receive R01 grant from National Cancer Institute to increase targeted cancer treatments to rural cancer patients
University of Kansas Cancer Center

TEAMSPORT will create a standardized approach to ordering genomic tests and adapt it for use in community cancer centers, where most cancer patients receive testing and treatment.

Released: 1-Nov-2022 9:45 AM EDT
The University of Kansas Cancer Center Partners with Nation’s Top Cancer Organizations to Endorse Initiative to Increase Lung Cancer Screening in the United States
University of Kansas Cancer Center

Joint call to action urges individuals, providers and insurers to increase access to and utilization of low-dose CT screening for those at high risk for lung cancer.

Newswise: Kansas Governor issues proclamation to honor The University of Kansas Cancer Center’s earning highest designation from the National Cancer Institute
Released: 1-Sep-2022 9:05 PM EDT
Kansas Governor issues proclamation to honor The University of Kansas Cancer Center’s earning highest designation from the National Cancer Institute
University of Kansas Cancer Center

Kansas Governor Laura Kelly has proclaimed September “Comprehensive Cancer Centers Awareness Month” in recognition of The University of Kansas Cancer Center becoming designated as a “Comprehensive” cancer center by the National Cancer Institute (NCI).

Newswise: KU Cancer Center researchers discover that people with blood-related cancers have a higher chance of COVID breakthrough infections
Released: 12-Aug-2022 9:30 AM EDT
KU Cancer Center researchers discover that people with blood-related cancers have a higher chance of COVID breakthrough infections
University of Kansas Cancer Center

Individuals with blood-related cancers are more likely to experience a COVID-19 infection even after being vaccinated, a University of Kansas Cancer Center study has found.

Newswise: The University of Kansas Cancer Center earns National Cancer Institute’s most prestigious status —Comprehensive
Released: 7-Jul-2022 10:30 AM EDT
The University of Kansas Cancer Center earns National Cancer Institute’s most prestigious status —Comprehensive
University of Kansas Cancer Center

The University of Kansas Cancer Center has been designated as a “Comprehensive” cancer center by the National Cancer Institute (NCI). This is the highest level of recognition awarded by the NCI and is the gold standard for cancer centers.

Newswise: Varenicline Increases Smoking Cessation Rates for African American Smokers
Released: 14-Jun-2022 1:05 PM EDT
Varenicline Increases Smoking Cessation Rates for African American Smokers
University of Kansas Cancer Center

Researchers at The University of Kansas Cancer Center have released the results of a clinical trial that examined the effectiveness of varenicline in African Americans. In their study published in JAMA, African American daily smokers who were given varenicline while receiving counseling had significantly greater quit rates than those who received a placebo.



close
0.12526